We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why so slow in announcing this? This has been known for a month on bidstats. Looks like only made it on one of the four lots. Lot 3 is the one to be in, just 9 suppliers on that one.
More bad news mr nalakapala eh?
Two lots of excellent news today:
- "successful with its tender for the Lot 4 Framework Agreement under Public Health England's ("PHE") National Microbiology Framework to provide its Clinical Laboratory Diagnostic Testing Services"
- "added to the UK Government's approved list as a private provider of day two and day eight ("D2/D8") coronavirus testing for all international arrivals for both SARS-CoV-2 PCR testing and SARS-CoV 2 genome sequencing testing services"
Https://uk.advfn.com/stock-market/london/sourcebio-SBI/share-news/SourceBio-International-PLC-National-Framework-con/85163761
The worry now for me is that investors are discounting Covid testing future income. Obviously there is cash and 'some' (difficult to quantify ) future covid testing earnings but strip that out completely and this is still massively overpriced imo so could yet be a way to fall or it could be getting close to a true value - but its got to be more about how its developing its core business. Without positives on that it will continue to drift imo. No way is testing going to move it back anywhere near the 230 mark. Any contarary opinions?
The price is clear. It wasnt the point of my comment. I am sorry if it wasnt quite as 'astute' as your next to last comment. How does your last comment help? The chat lines are supposed to be for those interested in chat about the stock - either agree/disagree - its all for the mix. What doesnt really add anything is sarcasm or abuse - that usually is the domain of the keyboard warriors on facebook.
Stock down from a 53 week high of 237.5, yeah 'astute'
Another drop in the bid. Unless there is something to come it cant be on the trading so it looks like the mm's dont want any more of the 23.3% available stock - even though its about 30% off its IPO high
"no friends" ... other than 76.7% of shares being tightly held by institutional investors and management, including some of the most astute investors in the country. Yeah ... no friends!!
Can't see where this will bottom out. Stock has no friends.
What is interesting is that a very few very small buys and the book changed so there is possibly a coiled spring due to only about 20% of the stock in play as one poster suggested some time ago
Don - if you are only interested in optimism why bother with a chat board? Just buy as many shares as you can afford.
I am happy to read most comments from wildly optimistic to wildly pessimistic. The reality (which is what Im trying to decide) is usually somewhere between the two. If it helps - £5 by Christmas so fill yer boots
Phoenix.
Results were posted on 13th
Killik have been selling and maybe still are (it looks like someone has possibly been selling) but no evidence yet that its killik is there?
Nalakapala ever the " optimist"
There is a seller. Killik and partners selling. Also results were due 13th April and not announced yet. I’m a holder and will definitely top up. Looks like we are on supplier list for both corona testing and our core business of histopathology in National framework.
2 NHS framework for contracts released totalling 25 billions.
https://twitter.com/chandragosavi/status/1384158779114082315?s=21
Looks like not many people read it. No change in sentiment. If the board can be believed no one bought Friday and although there werent many and mainly small I see the last one went through at 170 so probably another drop Monday am. This is the worry - the constant drip down to a point where its re rated
Excellent write-up on SBI published today by the Private Punter - here's a direct link (I'll also copy this to the EKF thread since it's also relevant there - I hold EKF too):
Https://martinflitton1.wixsite.com/privatepunter/post/sourcebio-international-when-cheap-may-not-prove-expensive-21-04-21
So 60.4p EPS is forecast this year - with a £51m cash pile, i.e almost 40% of the current m/cap!
That reduces to 15.4p EPS next year, but with the cash pile rising to £72.8m.
I agree with the writer and the Chariman that COVID testing is here to stay for some considerable time. With this, plus the likelihood of sizeable earnings-enhancing acquisitions, plus bounce back growth from the core business, SBI's value at these levels looks even more stark.
"But they wouldn’t have selected you in first place out of so many applicants."
There won't have been that many bidders.
"Other waist what’s the point of tender process?"
To get as many potential suppliers onto the framework, in order - when something is required - the capacity is there. Being on a framework is no guarantee of getting an order - particularly with this current administration.
SBI will get work but eh board are being canny and spreading their bets.
Hi Bakky fully aware of that. Same discussion going on at YGEN. But they wouldn’t have selected you in first place out of so many applicants. Other waist what’s the point of tender process?
don't forget that being on the supplier list does not guarantee any work unfortunately! Hopefully everyone who's made the list will come out with something worthwhile.
PHE's announcements have given a boost to YGEN & GDR this morning but no positive action here (YGEN & GDR issued RNS's)
https://bidstats.uk/tenders/2021/W15/749076498
New contract award announced yesterday for SBI as part of National Microbiology Framework - Lot 4: Clinical Laboratory Diagnostic Testing Services (share of £15 billion over the next 4 years).......
hTTps://bidstats.uk/tenders/2021/W15/749076498
https://twitter.com/chandragosavi/status/1383638608087687173?s=21
More NHS contracts! Steadily market cap will build up. Sometimes it takes time for the market to catch up. More IIs will be interested in company soon.
IDH Would make a nice fit and it also sitting on a large cash pile to boot.
Dont post good news here mah friend the haters will rubbish it.
New interview on Vox from 2:30mins - lots of excitement to come, including potential acquisitions from the fast-growing cash pile and I suspect more news re COVID-19 testing (including LFTs) - which is now expected to continue until 2024:
hTTps://www.**********.co.uk/articles/sourcebio-sees-significant-growth-and-vietnam-holding-s-positive-monthly-update-john-meyer-9654929/